Beta-Blockers Should Not Be First in Line for Treating Hypertension
In a meta-analysis, lowering of heart rate was associated with increases in cardiac mortality, risk for nonfatal MI, and heart failure.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)